Solution-phase parallel Wittig olefination: Synthesis of substituted 1,2-diarylethanes

Journal of Combinatorial Chemistry

Volumn 5, Issue 5, 2003, Pages 606-609

  Husemoen, Gitte ^a   Olsson, Roger ^a   Andersson, Carl Magnus ^a   Harvey, Scott C ^a   Hansen, Henrik C ^b  

^a ACADIA PHARMACEUTICALS INC   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKANE DERIVATIVE; SARPOGRELATE; SEROTONIN 2A AGONIST;

ACYLATION; ALKYLATION; AQUEOUS SOLUTION; ARTICLE; DEPROTECTION REACTION; HORNER REACTION; IC 50; REDUCTION; SOLID PHASE EXTRACTION; SYNTHESIS;

EID: 0141795489     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc0300210     Document Type: Article

References (17)

1. For a recent review, see: Meltzer, H. Y. Neuropsychopharmacology 1999, 21, S106-S115.
2. Weiner, D. M.; Burstein, E. S.; Nash, N.; Croston, G. E.; Currier, E. A. ; Vanover, K. E.; Harvey, S. C.; Donohue, E.; Hansen, H. C.; Andersson, C. M.; Spalding, T. A.; Gibson, D. F. C.; Krebs-Thomson, K.; Powell, S. B.; Geyer, M. A.; Hacksell, U.; Brann, M. R. J. Pharmacol. Exp. Ther. 2001, 299, 268-276.
3. Tanaka, N.; Goto, R.; Ito, R.; Hayakawa, M.; Ogawa, T.; Fujimoto, K. Chem. Pharm. Bull. 1998, 46, 639-646.
4. Besides antipsychotic activity, 1,2-diarylethanes are known anticonvulsants and have shown antithrombotic activity. See: (a) Kikumoto, R.; Tobe, A.; Fukami, H.; Ninomiya, K.; Egawa, M. J. Med. Chem. 1984, 27, 645-649. (b) Kikumoto, R.; Hara, H.; Ninomiya, K.; Osakabe, M.; Sugano, M.; Fukami, H.; Yoshikuni, T. J. Med. Chem. 1990, 33, 1818-1823.
5. Besides antipsychotic activity, 1,2-diarylethanes are known anticonvulsants and have shown antithrombotic activity. See: (a) Kikumoto, R.; Tobe, A.; Fukami, H.; Ninomiya, K.; Egawa, M. J. Med. Chem. 1984, 27, 645-649. (b) Kikumoto, R.; Hara, H.; Ninomiya, K.; Osakabe, M.; Sugano, M.; Fukami, H.; Yoshikuni, T. J. Med. Chem. 1990, 33, 1818-1823.
6. For libraries from libraries, see: (a) Ostresh, J. M.; Husar, G. M.; Blondelle, S. E.; Dörner, B.; Weber, P. A.; Houghten, R. A. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 11138-11142. (b) Houghten, R. A.; Blondelle, S. E.; Dooley, C. T.; Dörner, B.; Eichler, J.; Ostresh, J. M. Mol. Diversity 1996, 2, 41-45.
7. For libraries from libraries, see: (a) Ostresh, J. M.; Husar, G. M.; Blondelle, S. E.; Dörner, B.; Weber, P. A.; Houghten, R. A. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 11138-11142. (b) Houghten, R. A.; Blondelle, S. E.; Dooley, C. T.; Dörner, B.; Eichler, J.; Ostresh, J. M. Mol. Diversity 1996, 2, 41-45.
8. von Itzstein, M.; Mocerino, M. Synth. Commun. 1990, 20, 2049-2057.
9. Trippett, S.; Walker, D. M. J. Chem. Soc. 1961, 2130-2133.
10. For examples, see: (a) Charette, A. B.; Janes, M. K.; Boezio, A. A. J. Org. Chem. 2001, 66, 2178-2180. (b) Pelletier, J. C.; Kincaid, S. Tetrahedron Lett. 2000, 41, 797-800. (c) Tunoori, A. R.; Dutte, D.; Georg, G. I. Tetrahedron Lett. 1998, 39, 8751-8754.
11. For examples, see: (a) Charette, A. B.; Janes, M. K.; Boezio, A. A. J. Org. Chem. 2001, 66, 2178-2180. (b) Pelletier, J. C.; Kincaid, S. Tetrahedron Lett. 2000, 41, 797-800. (c) Tunoori, A. R.; Dutte, D.; Georg, G. I. Tetrahedron Lett. 1998, 39, 8751-8754.
12. For examples, see: (a) Charette, A. B.; Janes, M. K.; Boezio, A. A. J. Org. Chem. 2001, 66, 2178-2180. (b) Pelletier, J. C.; Kincaid, S. Tetrahedron Lett. 2000, 41, 797-800. (c) Tunoori, A. R.; Dutte, D.; Georg, G. I. Tetrahedron Lett. 1998, 39, 8751-8754.
13. For examples, see: (a) Westman, J. Org. Lett. 2001, 3, 3745-3747. (b) Sieber, F.; Wentworth, P., Jr.; Toker, J. D.; Wentworth, A. D.; Metz, W. A.; Reed, N. N.; Janda, K. D. J. Org. Chem. 1999, 64, 5188-5192.
14. For examples, see: (a) Westman, J. Org. Lett. 2001, 3, 3745-3747. (b) Sieber, F.; Wentworth, P., Jr.; Toker, J. D.; Wentworth, A. D.; Metz, W. A.; Reed, N. N.; Janda, K. D. J. Org. Chem. 1999, 64, 5188-5192.
15. Hansen, H. C.; Olsson, R.; Croston, G.; Andersson, C.-M. Bioorg. Med. Chem. Lett. 2000, 10, 2435-2439.
16. R-SAT is a mammalian cell-based assay technology that provides a sensitive measure of receptor function. Brann, M. R. U.S. Patent 5,707,798; 1988. Chem. Abstr. 1998, 128, 111548.
17. R-SAT is a mammalian cell-based assay technology that provides a sensitive measure of receptor function. Brann, M. R. U.S. Patent 5,707,798; 1988. Chem. Abstr. 1998, 128, 111548.